Bio-Reference Labs (BRLI) Tops Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq futures tumble as Amazon, Intel results deepen AI spending woes
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Six killed in cyclone off India's eastern coast
- Amazon (AMZN) Misses Q3 EPS by 7c, Misses on Revenue; Offers Q4 Revenue Guidance
- Sandisk announces 8-for-1 forward stock split effective November 2026
- Reddit, Inc. (RDDT) Tops Q3 EPS by 7c, Beats on Revenue; Offers Q4 Revenue Guidance
- SanDisk stock falls ahead of earnings report
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
- After-Hours Movers: WDC, BE, DECK, FIX, RNG
BioReference Laboratories, Inc. Reports Record Quarterly Revenues and Patient Volumes for Third Quarter FY2014
August 27, 2014 8:30 AM EDTELMWOOD PARK, N.J., Aug. 27, 2014 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc. (Nasdaq: BRLI) announces record third quarter results for revenues and patient volumes. Except for per share data or where otherwise noted, numbers are in thousands.
The Company recorded Q3FY14 revenues of $222,053, the highest recorded revenues in a quarter in corporate history, representing an increase of 20% over the $185,427 recorded in Q3FY13. Operating income for Q3FY14 was $27,871, up 11% from the Q3FY13 operating income of $25,059. Net income after taxes in Q3FY14 came in at $15,250, resulting in earnings... More



